CERULEAN PHARMA INC's ticker is CERU and the CUSIP is 15708Q105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $14,596,000 | +446.5% | 3,287,529 | 0.0% | 15.10% | +428.3% |
| Q1 2017 | $2,671,000 | +14.7% | 3,287,529 | 0.0% | 2.86% | +3.5% |
| Q4 2016 | $2,328,000 | -32.4% | 3,287,529 | 0.0% | 2.76% | -24.0% |
| Q3 2016 | $3,442,000 | -50.6% | 3,287,529 | 0.0% | 3.63% | -51.4% |
| Q2 2016 | $6,970,000 | -21.8% | 3,287,529 | 0.0% | 7.48% | -12.1% |
| Q1 2016 | $8,909,000 | -3.2% | 3,287,529 | 0.0% | 8.51% | +17.7% |
| Q4 2015 | $9,205,000 | -23.5% | 3,287,529 | 0.0% | 7.23% | -11.8% |
| Q3 2015 | $12,032,000 | -20.4% | 3,287,529 | 0.0% | 8.20% | +21.5% |
| Q2 2015 | $15,123,000 | -48.9% | 3,287,529 | 0.0% | 6.74% | -49.0% |
| Q1 2015 | $29,621,000 | +44.9% | 3,287,529 | 0.0% | 13.23% | -18.2% |
| Q4 2014 | $20,448,000 | +47.4% | 3,287,529 | 0.0% | 16.18% | +51.1% |
| Q3 2014 | $13,873,000 | -27.2% | 3,287,529 | 0.0% | 10.71% | -31.1% |
| Q2 2014 | $19,068,000 | – | 3,287,529 | – | 15.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Deer VII & Co. Ltd. | 166,675 | $118,000 | 5.03% |
| Polaris Venture Management Co. V, L.L.C. | 3,287,529 | $2,328,000 | 2.76% |
| Rock Springs Capital Management LP | 625,000 | $443,000 | 0.03% |
| Artemis Wealth Advisors, LLC | 8,810 | $6 | 0.01% |
| Northeast Financial Consultants Inc | 20,000 | $14,000 | 0.01% |
| Sterling Investment Advisors, Ltd. | 5,877 | $4,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 202,623 | $144,000 | 0.00% |
| WEDBUSH SECURITIES INC | 16,000 | $11,000 | 0.00% |
| A.R.T. Advisors, LLC | 59,300 | $41,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 6,932 | $5,000 | 0.00% |